Anjali Singh

CV wholesale growth stayed strong in May; Icra sees moderation in FY27

Commercial vehicle wholesales rose 13.5 per cent in May, supported by GST cuts and a favourable base, but ICRA expects growth to moderate to 4-6 per cent in FY27

Zydus, Sunshine Healthcare form $20-million JV for Sri Lanka pharma plant

The joint venture will invest over $20 million in a pharmaceutical manufacturing facility in Sri Lanka to boost local drug production and reduce reliance on imports

DRL gets 7 observations after USFDA inspection of Hyderabad biologics plant

USFDA completed a pre-license inspection of the Hyderabad facility and issued a Form 483 with seven observations, which the company said it will address within the stipulated timeline

Electric commercial vehicle adoption near tipping point: Tata Motors

Tata Motors says commercial vehicle electrification is nearing a tipping point, driven by improving economics, localisation and policy support

Tata Motors to begin isobutanol-blended diesel truck trials next quarter

Tata Motors to begin pilot trials of trucks running on 2% isobutanol-blended diesel next quarter as India explores alternative fuels to cut oil imports

Indian drugmakers line up for Keytruda biosimilar race as patents near end

Biocon, Zydus, Dr Reddy's are among companies positioning for one of the largest biosimilar launches for cancer treatment

Novo Nordisk in touch with authorities over alleged 1 TB data breach claims

The drugmaker said it is monitoring its systems and maintaining normal operations after reports that a hacking group claimed to have stolen and published company data

Medicover keeps IPO pulse steady as KKR examines India hospital deal

The hospital chain said its planned public listing remains the preferred route even as parent company Medicover AB holds preliminary discussions with KKR

e2W makers ramp up capacity as dealers flag shortages of high-demand models

Electric two-wheeler makers are expanding capacity as rising demand and model-specific shortages lead to longer delivery timelines in several markets

Indian pharma's next prescription: Specialty drugs, not just generics

Indian drugmakers are reducing reliance on US generics, turning to specialty medicines, biosimilars and emerging markets to drive sustainable growth

Cipla expands respiratory, specialty manufacturing across India, China, US

Filed 10 applications with USFDA in FY26 to build a pipeline of differentiated products for regulated markets

Carmakers embrace price hikes to offset rising input, manufacturing costs

Automakers are increasingly opting for smaller, more frequent price increases to offset rising input and manufacturing costs, rather than implementing annual hikes

Generic semaglutide market shows signs of excess inventory bulge

Distributors grapple with rising semaglutide inventory amid slower liquidation

Heatwaves may be causing hidden health stress among working Indians: Study

An analysis of more than 22,000 health records found rising signs of dehydration, electrolyte imbalance and kidney stress among healthy adults during peak summer months

Quest Global flags workplace impact of miscarriage, launches support drive

A study by Quest Global highlights the workplace and career impact of pregnancy loss and calls for structured employer support to improve retention and inclusion

BMW bets on localisation, Tier-2 expansion to double MINI sales in India

The luxury carmaker plans to drive growth through local assembly of the MINI Countryman, expansion into 10 new cities and a broader product portfolio

India's GLP-1 market enters slower growth phase after semaglutide surge

After a near fourfold expansion driven by generic semaglutide launches, India's GLP-1 market is showing signs of moderation as patient onboarding growth slows

Beyond GLP-1, Novo eyes next-gen obesity drugs: Vikrant Shrotriya

Novo Nordisk plans to defend its obesity drug leadership in India as semaglutide patent expiry fuels competition from nearly 50 new market entrants

Uzbekistan eyes Indian pharma firms to achieve $10 bn output by 2035

The Central Asian nation is offering tax breaks, infrastructure support and regulatory incentives as it seeks to become a pharmaceutical manufacturing hub for the CIS region

PM Modi meets Citigroup Chair Jane Fraser, discusses investment plans

The Prime Minister and Citi Chair Jane Fraser discussed investment opportunities, capital flows, artificial intelligence and alternative energy as part of India's long-term growth agenda